Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00519831
Status:
TERMINATED
Last Update Posted:
2017-06-09
First Post:
2007-08-21
Brief Title:
Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
Sponsor:
Organization:
UNC Lineberger Comprehensive Cancer Center